(PRESPEND)Prot# FVF2587g: A Phs III, Mlticntr, Rndmzd, Dbl-Masked, Active Trtmnt-Cntrlld Study of the Efficacy & Safety of rhuFab V2 (Ranibizumab) Compared w/Verteporfin (Visudyne?) Photodynamic Therapy in Subjects w/Predominantly Classic Subfoveal Neovas

Project: Research project

Project Details

StatusFinished
Effective start/end date2/3/042/3/05

Funding

  • Genentech, Inc. (PRESPEND)
  • University of Wisconsin-Madison (PRESPEND)